| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Achieve Life Sciences, Inc.
13D
ACHV · 004468500
|
10.0% |
4/27/2026
Event 4/15/2026
|
||||
| venBio Global Strategic Fund V, L.P. | 10.0% | |||||
| venBio Global Strategic GP V, LLC | 10.0% | |||||
| Schedule 13G · 1 security · passive | ||||||
|
Yarrow Bioscience, Inc.
13G
YARW · 92941V407
|
10.0% |
8/14/2026
Event 7/27/2026
|
||||
| venBio Global Strategic Fund V, L.P. | 10.0% | |||||
| venBio Global Strategic GP V, LLC | 10.0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.